Can Eurofins Viracor’s BKV inSIGHT panel solve a dangerous kidney transplant monitoring blind spot?
Eurofins Viracor launches BKV inSIGHT for BK virus T-cell monitoring, but adoption will depend on validation and treatment-guidance evidence.
Eurofins Viracor launches BKV inSIGHT for BK virus T-cell monitoring, but adoption will depend on validation and treatment-guidance evidence.
Eurofins Viracor adds rapid CXCL9, CXCL10 and IL-18 plasma assays, but clinical utility, logistics and reimbursement will shape adoption.